Диссертация (1140625), страница 22
Текст из файла (страница 22)
Clin. Microbiol. – 2017. - Vol. 55. - № 10. – P. 2894-2902.178. Nijhuis, R. H. High levels of macrolide resistance-associated mutations inMycoplasma genitalium warrant antibiotic susceptibility-guided treatment / R. H.Nijhuis, T. T. Severs, D. S. Van der Vegt // J.
Antimicrob. Chemother. - 2015. -70. Vol.9. – P. 2515–2518.179. Oakeshott, P. Is Mycoplasma genitalium in women the “new chlamydia?”A community-based prospective cohort study / P. Oakeshott, A. Aghaizu, P. Hay //Clin. Infect. Dis. – 2010. - Vol. 51. - № 10. – P. 1160-1116.180. Oliphant, J. Cervicitis: limited clinical utility for the detection ofMycoplasma genitalium in a cross-sectional study of women attending a New Zealandsexual health clinic / J. Oliphant, S. Azariah // Sexual Health. - 2013. – Vol. 10. – P.263–267.181. Olsen, B. Population-based assessment of Mycoplasma genitalium inVietnam—low prevalence among married women of reproductive age in a rural area /B.
Olsen, P. Lan, C. Stalsby Lundborg [et al.] // Eur. Acad. Dermatol. Venereol. –2009. - Vol. 23. - № 5. – P. 533-537.182. Ona, S. Mycoplasma genitalium: an overlooked sexually transmittedpathogen in women? / S. Ona, R. Molina, K. Diouf // Infect. Dis. Obstet.
Gynecol. 2016. - URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860244/#B15 (date ofthe application 10.11.2017).183. Paulsen, L. Prevalence of M.genitalium and U.urealyticum in urine testedfor C. rachomatis / L. Paulsen, M. Dahl, D. Skaare [et al.] // Tidsskr. Nor. Laegeforen. –2016.
- Vol. 136. - №2. – P. 121-125.184. Paz-Bailey, G. High rates of STD and sexual risk behaviors amongGarífunas in Honduras / G. Paz-Bailey, S. Morales-Miranda, J. Jacobson [et al.] // J.Acquir. Immune Defic. Syndr. – 2009. - Vol. 51. - № 1. – P. 26-34.185. Pereyre, S. Mycoplasma genitalium and Trichomonas vaginalis in France: apoint prevalence study in people screened for sexually transmitted diseases / S. Pereyre,127C. Laurier Nadalie, C.
Bebear // Clin. Microbiol. Infect. – 2017. - Vol. 23. - № 2. – P.1221-1227.186. Polatti, F. Bacterial vaginosis, Atopobium vaginae and Nifuratel / F.Polatti // Current Clinical Pharmacology. – 2012. – Vol. 7. – P. 36-40.187. Powell, A. Recurrent vulvovaginitis / A.M. Powell, P. Nyirjesy // BestPract. Res. Clin. Obstet. Gynaecol. – 2014. – Vol.
7. – P. 967-976.188. Quentin, R. Microbiologic basis of diagnosis and treatment of pelvicinflammatory disease / R. Quentin, R. Verdon // Journal de gynecologie obstetrique etbiologie de la reproduction. – 2012. – Vol. 41. - № 8. - P. 850–863.189. Rajkumari, N. Association of Mycoplasma genitalium with infertility inNorth Indian women / N. Rajkumari, H. Kaur, A. Roy [et al.] // Indian J.
Sex. Transm.Dis. AIDS. – 2015. - Vol. 36. - № 2. – P. 144-148.190. Reinton, N. Anatomic distribution of Neisseria gonorrhoeae, Chlamydiatrachomatis and Mycoplasma genitalium infections in men who have sex with men / N.Reinton, H. Moi, A. Olsen [et al.] // Sex.
Health. – 2013. - Vol. 10. - № 3. – P. 199203.191. Ross, J. Mycoplasma genitalium in asymptomatic patients: implications forscreening / J. Ross, L. Brown, P. Saunders // Sexually Transmitted Infections. - 2009. –Vol. 85. - № 6. - P. 436–437.192. Samra, Z. Direct simultaneous detection of 6 sexually transmittedpathogens from clinical specimens by multiplex polymerase chain reaction and autocapillary electrophoresis / Z. Samra, S.
Rosenberg, L. Madar-Shapiro // Diagn.Microbiol. Infect. Dis. – 2011. – Vol. 70. – P. 17–21.193. Schwebke, J. R. Re-evaluating the treatment of nongonococcal urethritis:emphasizing emerging pathogens - a randomized clinical trial / J. R. Schwebke, A.Rompalo, S. Taylor [et al.] // Clin. Infect. Dis. – 2011. – Vol. 52. – P. 163–170.194. Sethi, S. Mycoplasma genitalium: an emerging sexually transmittedpathogen / S. Sethi, G. Singh, P.
Samanta [et al.] // Indian J. Med. Res. – 2012. - Vol.136. - № 6. – P. 942-955.128195. Sexually transmitted diseases treatment guidelines / K. A. Workowski, G.A. Bolan // Morbidity and mortality weekly report. – 2015. – Vol. 64. - № 3. – P. 1-137.196. Shimada, Y. Macrolide resistance-associated 23S rRNA mutation inMycoplasma genitalium, Japan / Y. Shimada, T. Deguchi, K. Nakane [et al.] // Emerg.Infect. Dis.
– 2011. – Vol. 17. № 6. – P. 1148–1150.197. Shipitsyna, E. Prevalence of macrolide and fluoroquinolone resistancemediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia[Electronic resource] / E. Shipitsyna, T. Rumyantseva, D. Golparian [et al.] // PLoSOne. – 2017. - URL: https://doi.org/10.1371/journal.pone.0175763 (date of theapplication 11.10.2017).198.
Simms, I. Associations between Mycoplasma genitalium, Chlamydiatrachomatis and pelvic inflammatory disease / I. Simms, K. Eastick, H. Mallinson //Sex. Transm. Infect. — 2009. — Vol. 79. — P. 154 - 156.199. Sonnenberg, P. Epidemiology of Mycoplasma genitalium in British menand women aged 16–44 years: evidence from the third National Survey of SexualAttitudes and Lifestyles (Natsal-3) / P.
Sonnenberg, C.A. Ison, S. Clifton [et al.] // Int. J.Epidemiol. – 2015. - Vol. 44. - № 6. – P. 1982-1994.200. Swift, B. E. The effect of age, ethnicity, and level of education on fertilityawareness and duration of infertility / B. E. Swift, K. E. Liu // J. Obstet.
Gynaecol. Can.– 2014. – Vol. 36. – P. 990–996.201. Sexual debut before the age of 14 leads to poorer psychosocial health andrisky behaviour in later life / A. A. Kastbom [et al.] // Acta Paediatrica. - 2015. - Vol.104. - № 1. - P. 91–100.202. Taylor-Robinson, D. Difficulties experienced in defining the microbialcause of pelvic inflammatory disease / D.
Taylor-Robinson, Н. Jensen [et al.] // Int. J.STD AIDS - 2012. – Vol. 23. - P. 18–24.203. Taylor-Robinson,D.Mycoplasmagenitalium:fromchrysalistomulticolored butterfly / D. Taylor-Robinson, J. Jensen // Clin. Microbiol. Rev. - 2011. –Vol. 24.- № 3. - P. 498–514.129204. Thurman, A. Mycoplasma genitalium symptoms, concordance andtreatment in high-risk sexual dyads / A. Thurman, O. Musatovova, S. Perdue [et al.] //Int. J.
STD AIDS. – 2015. - Vol. 21. - № 3. - P. 177-183.205. Trembizki, E. High levels of macrolide-resistant Mycoplasma genitalium inQueensland, Australia / E.Trembizki, C. Buckley, C. Bletchly // J. Med. Microbiol. –2017. – Vol.66. - №10. - P.1451-1453.206. Togni, G. In vitro activity of nifuratel on vaginal bacteria: could it be agood candidate for the treatment of bacterial vaginosis? / G. Togni, V. Battini, A.Bulgheroni, et al. // Antimicrob. Agents Chemother.
– 2011. – Vol. 55. – P. 2490- 2492.207. Tosheva-Daskalova, K. Multiplex PCR detection of problematic pathogensof clinically heterogeneous bacterial vaginosis in Bulgarian women / K. ToshevaDaskalova, T. V. Strateva, I. G. Mitov [et al.] // Turkish journal of medical sciences. –2017. - Vol. 5. – P. 1492-1499.208. Trent, M. Clinical and sexual risk correlates of Mycoplasma genitalium inurban pregnant and non-pregnant young women: cross-sectional outcomes using thebaseline data from the Women's BioHealth Study [Electronic resource] / M. Trent, J.S. Coleman, J.
Perin [et al.] // Sex. Transm. Infect.– 2017. –URL:https://sti.bmj.com/content/early/2017/03/29/sextrans-2017-053367.long (date of theapplication 25.08.2017).209. Twin, J. Transmission and selection of macrolide resistant Mycoplasmagenitalium infections detected by rapid high resolution melt analysis / J. Twin, J. S.Jensen,C.S.Bradshaw[etal.]//PLoSOne.–2012.-URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331984/ (date of the application11.02.2016).210.
Unemo, M. Antimicrobial-resistant sexually transmitted infections:gonorrhoea and Mycoplasma genitalium / M. Unemo, J. S. Jensen // Nat. Rev. Urol. –2017. –Vol. 14. -№ 3. - P. 139–152.211. Unemo, M. Five-day azithromycin treatment regimen for Mycoplasmagenitalium infection also effectively eradicates chlamydia trachomatis / M. Unemo, K.M. Endre, H. Moi // Acta. Derm. Venereol. – 2015. - Vol. 95. - № 6. - P.730–732.130212. Vandepitte, J.
Association between Mycoplasma genitalium infection andHIV acquisition among female sex workers in Uganda: evidence from a nested casecontrol study / J. Vandepitte, H. Weiss, J. Bukenya [et al.] // Sex. Transm. Infect. –2014. – Vol. 90.- P. 545-549.213. Walker, J. The difference in determinants of Chlamydia trachomatis andMycoplasma genitalium in a sample of young Australian women [Electronic resource] /J. Walker, C. Fairley, C. Bradshaw [et al.] // BMC Infect Dis. – 2011.
– URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038161/ (date of the application24.08.2016).214. Weinstein, S. A review of the epidemiology, diagnosis and evidence- basedmanagement of Mycoplasma genitalium / S. Weinstein, B. Stiles // Sex Health. – 2011.– Vol. 8. - № 2. - P. 143–158.215. Wiesenfeld, H.
C. Mycoplasma genitalium in women: current knowledgeand research priorities for this recently emerged pathogen / H. C. Wiesenfeld, L. E.Manhart // J. Infect. Dis. – 2017. - Vol. 216. - № 2. - Р. 389 - 395.216. Wiesenfeld, H. C. Subclinical pelvic inflammatory disease and infertility /H. C. Wiesenfeld, S. L.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
